Sign in
Taking peopleNo phase

Prognostic Power of the VEXUS Score in Septic Shock: Effectiveness in Mortality Prediction

Key facts

Who runs it
Antalya Training and Research Hospital
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
100 people, planned
Started
30 Mar 2026
Expected to end
20 Dec 2026
Type of study
Observational
Treatments tested
  • Serial VEXUS Ultrasound Evaluation
Record updated
22 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (12)Hide the full registry criteria

Who can take part

  • Age>18
  • Patients monitored for septic shock in intensive care unit
  • Signed informed consent

Who cannot take part

  • Patients in whom venous structures cannot be clearly assessed via ultrasonography due to anatomical or technical reasons (e.g., adhesions following abdominal surgery)
  • Patients receiving dialysis due to chronic kidney disease or initiating dialysis for acute kidney failure
  • Chronic heart failure
  • Patients with advanced valvular insufficiency or advanced pulmonary hypertension
  • Patients with portal hypertension or advanced-stage liver cirrhosis
  • Presence of acute or chronic thrombosis in the inferior vena cava or other venous structures within the scoring area
  • Age <18
  • Severe obesity precluding adequate ultrasonographic imaging
  • Refusal to participate

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Septic shock or vexus

This trial is currently available in Türkiye.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to evaluate the prognostic power of the VEXUS Score in predicting mortality among patients with septic shock in intensive care units.

The group in the trial

  • Septic shock cohort

    All patients diagnosed with septic shock in the ıntensive care unit will undergo serial ultrasonographic evaluations to calculate the VEXUS Score at 0-4 hours, 12-24 hours, and 72 hours. These scores will be analyzed in relation to 28-day mortality. No treatment decisions will be made based on the VEXUS results.

    Treatment: Serial VEXUS Ultrasound Evaluation

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Prognostic Power of the VEXUS Score in Septic Shock: Efficacy in Mortality Prediction
Criteria questions
Built from NCT07124741, who can take part
Record updated
22 September 2026